IP Library Granted Patent US 9,988,608
Granted Patent B1
US 9,988,608 · App. 14/883,366 · Granted Jun 5, 2018

Methods of expanding bacteriophage host-range and bacteriophage produced by the methods

Inventors: Kevin K. Crown (Albuquerque, NM); Joshua Santarpia (Albuquerque, NM)
Assignee: National Technology & Engineering Solutions of Sandia, LLC
C12N7/00C12Q1/02C12N2795/00051
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,608
App. No.
14/883,366
Granted
Jun 5, 2018
Kind
B1
Abstract

A method of producing novel bacteriophages with expanded host-range and bacteriophages with expanded host ranges are disclosed. The method produces mutant phage strains which are infectious to a second host and can be more infectious to their natural host than in their natural state. The method includes repeatedly passaging a selected phage strain into bacterial cultures that contain varied ratios of its natural host bacterial strain with a bacterial strain that the phage of interest is unable to infect; the target-host. After each passage the resulting phage are purified and screened for activity against the target-host via double-overlay assays. When mutant phages that are shown to infect the target-host are discovered, they are further propagated in culture that contains only the target-host to produce a stock of the resulting mutant phage.

Claims (33)

1. A method of producing bacteriophages with expanded host-range, comprising:

determine that a selected phage strain infects a host bacterial strain and not a target-host bacterial strain, wherein the selected phage strain is a Clostridium sporogenes B1 phage or a Clostridium sporogenes B3 phage, the host bacterial strain is a first Clostridium sporogenes strain, and the target-host bacterial strain is a second Clostridium sporogenes strain;

culture the host bacterial strain and the target-host bacterial strain separately to obtain a host culture and a target-host culture, respectively;

mix the host culture and the target-host culture into various co-culture ratios of each, thereby obtaining a series of a plurality of first co-cultures;

add the selected phage strain to each of the plurality of first co-cultures;

add a predetermined mutagen to each of the plurality of first co-cultures, wherein the predetermined mutagen comprises mitomycin C;

incubate under bacterial culture conditions;

harvest a resulting phage from each of the plurality of first co-cultures and purify; and

apply the resulting phage to a subsequent set of co-cultures identical to the first co-cultures but naive to the phage.

2. A method of producing bacteriophages with expanded host-range, comprising:

determine that a selected phage strain infects a host bacterial strain and not a target-host bacterial strain, wherein the selected phage strain is a Clostridium sporogenes B1 phage or a Clostridium sporogenes B3 phage, the host bacterial strain is a first Clostridium sporogenes strain, and the target-host bacterial strain is a second Clostridium sporogenes strain;

subject the selected phage in bacterial co-cultures consisting of various ratios of the host bacterial strain and the target-host bacterial strain;

separate the host bacterial strain, the target-host bacterial strain, and a resulting phage;

assay the resulting phage against naïve host and target-host to determine if a host-expansion event has occurred;

repeat phage purification, passaging, and assaying for host-expansion into target-host until there is evidence of infecting activity against target-host bacterial strain; and

isolate a mutant phage and cultivate in naïve target-host culture to produce a population of phage mutant.

3. The method of claim 2 , further comprising:

combining one or more populations of mutant phages to produce a mutant phage cocktail.

4. The method of claim 1 , wherein the series of the plurality of first co-cultures comprises a ratio of 1:0, 9:1, 1:1, 1:9, and 0:1 of the host bacterial strain:the target-host bacterial strain.

5. The method of claim 1 , wherein the incubate step is performed under static, anaerobic conditions.

6. The method of claim 1 , wherein the resulting phage is a mutant phage comprising ssDNA genome.

7. The method of claim 1 , further comprising, after the apply step:

isolate the resulting phage; and

ensure the resulting phage infects the target-host bacterial strain, thereby identifying a host-expanded mutant phage.

8. The method of claim 7 , further comprising, after the ensure step:

propagate further the host-expanded mutant phage in a target-host culture.

9. The method of claim 1 , further comprising, after the apply step:

passaging the resulting phage cultivated in each co-culture ratio.

10. The method of claim 2 , wherein the bacterial co-cultures comprises a ratio of 1:0, 9:1, 1:1, 1:9, and 0:1 of the host bacterial strain:the target-host bacterial strain.

11. The method of claim 2 , wherein the subject step is performed under static, anaerobic conditions.

12. The method of claim 2 , wherein the mutant phage comprises ssDNA genome.

13. The method of claim 2 , further comprising, after the isolate step:

propagate further the mutant phage in a target-host culture.

Assignments (3)
CHANGE OF NAME Recorded Feb 2, 2018
From: SANDIA CORPORATION
To: NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC
Reel/Frame 045243/0572 →
CONFIRMATORY LICENSE Recorded Dec 22, 2015
From: SANDIA CORPORATION
To: U.S. DEPARTMENT OF ENERGY
Reel/Frame 037363/0727 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2015
From: CROWN, KEVIN K.; SANTARPIA, JOSHUA
To: SANDIA CORPORATION
Reel/Frame 037203/0432 →
Continuity (1)
Provisional Application 62063873 · Oct 14, 2014